Researchers are seeking to identify novel genes contributing to nicotine metabolism and to smoking cessation.
Innovative Science Overcomes Formulation Challenges
SRI is enabling and improving metabolomics research with high-quality reference standards.
Partnering to Advance Therapy for Radiation Exposure
For the National Institute of Mental Health (NIMH), SRI performs preclinical safety and pharmacokinetics studies for brain imaging agents and drugs to treat mental illnesses.